Encapsulation of PEGylated low-molecular-weight PEI polyplexes in hyaluronic acid hydrogels reduces aggregation
Source abstract
Abstract
The effective delivery of DNA locally could increase the applicability of gene therapy in tissue regeneration and therapeutic angiogenesis. One promising approach is through use of porous hydrogel scaffolds that incorporate and deliver DNA in the form of nanoparticles to the affected sites. While we have previously reported on caged nanoparticle encapsulation (CnE) to load DNA polyplexes within hydrogels at high concentrations without aggregation, frequent issues with limited polyplex release following CnE have been encountered. In this study, we report two alternative approaches to polyplex presentation for decreasing aggregation in porous hydrogels. The first approach reduces polyplex aggregation by utilizing polyethylene glycol modification of the gene carrier polymer polyethyleneimine (sPEG-PEI) to mitigate charge-charge interactions between polyplexes and the scaffold during gelation. The second approach electrostatically presents polyplexes on the surfaces of scaffold pores as opposed to an encapsulated presentation. The sPEG-PEI polymer formed a smaller, less toxic, and more stable polyplex that exhibited less aggregation within HA gels when compared to the traditionally used linear PEI (LPEI) polymer. Surface-coated polyplexes also resulted in a more homogenous distribution of polyplexes in hydrogels. Furthermore, sPEG-PEI polyplexes retained transfection abilities comparable to LPEI in 3D surface-coated transfections. These results demonstrate a significant improvement in scaffold-mediated gene delivery and show promise in applications to multi-gene delivery systems. Statement of significance A promising gene delivery approach for regenerative medicine is implanting porous hydrogel scaffolds loaded with DNA nanoparticles for delivery to affected sites. However, loading DNA polyplexes at high concentrations within hydrogels results in significant aggregation. Here, we describe two methods for decreasing aggregation of DNA polyplexes in porous gels. First, the gene carrier polymer polyethyleneimine (PEI) was modified with polyethylene glycol (sPEG-PEI) to mitigate the electrostatic interactions between polyplexes and scaffold polymer to in turn decrease aggregation. Second, polyplexes were presented along the surfaces of the pores of the hydrogel instead of being encapsulated within the gel. These methods allow for highly tunable and sustained transgene expression from scaffold-mediated gene delivery while avoiding polyplex aggregation.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Hydrogels: synthesis, properties, applications · Nanopore and Nanochannel Transport Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (31)
Show source-provided references
1. Tissue engineering: current state and perspectives10.1007/s00253-004-1580-z ↗
2. Tissue engineering: from biology to biological substitutes10.1089/ten.1995.1.3 ↗
3. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering10.1038/nbt1055 ↗
4. Matrix-based gene delivery for tissue repair
5. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration10.1038/10473 ↗
6. Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection10.1016/j.ymthe.2005.03.036 ↗
7. Non-viral vector delivery from PEG-hyaluronic acid hydrogels10.1016/j.jconrel.2007.04.015 ↗
8. Poly(ethylenimine) and its role in gene delivery10.1016/S0168-3659(99)00090-5 ↗
9. Design of cell-matrix interactions in hyaluronic acid hydrogel scaffolds
10. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants10.1016/j.biomaterials.2003.09.054 ↗
11. The effects of hyaluronic acid hydrogels with tunable mechanical properties on neural progenitor cell differentiation10.1016/j.biomaterials.2010.01.125 ↗
12. CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation10.1046/j.1523-1747.2001.00236.x ↗
13. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression10.1016/0955-0674(94)90100-7 ↗
14. Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells10.1242/jcs.105.1.213 ↗
15. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis10.1016/j.matbio.2009.11.002 ↗
16. Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering10.4161/org.4.4.6926 ↗
17. Matrix metalloproteinases and the regulation of tissue10.1038/nrm2125 ↗
18. Matrix metalloproteinases in repair10.1046/j.1524-475X.1999.00423.x ↗
19. DNA delivery from matrix metalloproteinase degradable poly(ethylene glycol) hydrogels to mouse cloned mesenchymal stem cells10.1016/j.biomaterials.2008.09.027 ↗
20. J.K.J. Kim, I.S.K.I.S. Kim, S.J.H.S.J. Hwang, H.C.K.H.C. Kim, Y.P.Y. Park, K.S.K. Sun, Bone regeneration using MMP sensitive-hyaluronic acid based hydrogels, 2009 IEEE 35th Annual Northeast Bioengineering Conference, 2009.
21. Synthesis and characterization of matrix metalloprotease sensitive-low molecular weight hyaluronic acid based hydrogels10.1007/s10856-008-3469-3 ↗
22. Incorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds10.1016/j.biomaterials.2010.08.016 ↗
23. Hyaluronic acid and fibrin hydrogels with concentrated DNA/PEI polyplexes for local gene delivery10.1016/j.jconrel.2011.01.028 ↗
24. Design and characterization of microporous hyaluronic acid hydrogels for in vitro gene transfer to mMSCs10.1016/j.actbio.2012.07.014 ↗
25. Non-viral DNA delivery from porous hyaluronic acid hydrogels in mice10.1016/j.biomaterials.2013.10.014 ↗
26. Porous hyaluronic acid hydrogels for localized nonviral DNA delivery in a diabetic wound healing model10.1002/adhm.201400783 ↗
27. Differential uptake of DNA-poly(ethylenimine) polyplexes in cells cultured on collagen and fibronectin surfaces10.1016/j.actbio.2010.03.038 ↗
28. Toward delivery of multiple growth factors in tissue engineering10.1016/j.biomaterials.2010.04.053 ↗
29. Biopolymeric delivery matrices for angiogenic growth factors10.1016/S1054-8807(03)00089-9 ↗
30. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation10.1007/s11095-006-9173-4 ↗
31. Delivery of non-viral gene carriers from sphere-templated fibrin scaffolds for sustained transgene expression10.1016/j.biomaterials.2007.07.026 ↗